
Search Search this site : Home News GenomeWeb Daily News BioArray News BioInform Clinical Sequencing News Gene Silencing News In Sequence PCR Insider PGx Reporter ProteoMonitor Magazine Blog The Daily Scan Cancer Minute Informatics Iron The Sample Careers Job Listings Video Resource Log in or Register Tuesday , July 31, 2012 Arrays MDx Informatics PCR Sample Prep Proteomics RNAi Sequencing Videos Home News Gene Silencing News Alnylam Reports Positive Phase I Data on ATTR Drug Sees Pfizer Drug Setback as FDA Guide July 19, 2012 Type size : Email Printer-friendly version RSS Feed By Doug Macron Full-text access for premium subscribers . only Existing premium subscribers login here New to GenomeWeb Register quickly here Doug Macron is the editor of GenomeWeb's Gene Silencing News He covers